Literature DB >> 11911622

Treatment of neonatal abstinence syndrome with breast milk containing methadone.

Jeanne L Ballard1.   

Abstract

This article addresses the management of pregnant women participating in a methadone maintenance program. An approach to management of the labor of a woman on a methadone maintenance program is described along with a summary of what to anticipate at delivery and postpartum, and options for management of the infant who manifests symptoms of the neonatal abstinence syndrome.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11911622     DOI： 10.1097/00005237-200203000-00008

Source DB:  PubMed          Journal:  J Perinat Neonatal Nurs        ISSN： 0893-2190            Impact factor:   1.638


  10 in total

1.  Concentrations of methadone in breast milk and plasma in the immediate perinatal period.

Authors:  Lauren M Jansson; Robin E Choo; Cheryl Harrow; Martha Velez; Jennifer R Schroeder; Ross Lowe; Marilyn A Huestis
Journal:  J Hum Lact       Date:  2007-05       Impact factor: 2.219

2.  Estimated infant exposure to enantiomer-specific methadone levels in breastmilk.

Authors:  Debra L Bogen; James M Perel; Joseph C Helsel; Barbara H Hanusa; Matthew Thompson; Katherine L Wisner
Journal:  Breastfeed Med       Date:  2011-02-24       Impact factor: 1.817

3.  Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial.

Authors:  M S Brown; M J Hayes; L M Thornton
Journal:  J Perinatol       Date:  2014-10-30       Impact factor: 2.521

4.  Unpacking Perinatal Experiences with Opioid Use Disorder: Relapse Risk Implications.

Authors:  Lela Rankin; Natasha S Mendoza; Lisa Grisham
Journal:  Clin Soc Work J       Date:  2022-05-19

5.  ABM clinical protocol #21: Guidelines for breastfeeding and the drug-dependent woman.

Authors:  Lauren M Jansson
Journal:  Breastfeed Med       Date:  2009-12       Impact factor: 1.817

6.  Pharmacologic evidence to support clinical decision making for peripartum methadone treatment.

Authors:  D L Bogen; J M Perel; J C Helsel; B H Hanusa; M Romkes; T Nukui; C R Friedman; K L Wisner
Journal:  Psychopharmacology (Berl)       Date:  2012-08-25       Impact factor: 4.530

7.  Corrected QT Interval and Methadone Dose and Concentrations in Pregnant and Postpartum Women.

Authors:  Debra L Bogen; Barbara H Hanusa; James M Perel; Frederick Sherman; Marla A Mendelson; Katherine L Wisner
Journal:  J Clin Psychiatry       Date:  2017 Sep/Oct       Impact factor: 4.384

8.  Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation.

Authors:  Uma M Reddy; Jonathan M Davis; Zhaoxia Ren; Michael F Greene
Journal:  Obstet Gynecol       Date:  2017-07       Impact factor: 7.623

9.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

10.  Feeding modalities and the onset of the neonatal abstinence syndrome.

Authors:  Anthony Liu; Jaime Juarez; Ajitha Nair; Ralph Nanan
Journal:  Front Pediatr       Date:  2015-02-26       Impact factor: 3.418
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.